Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today under the symbol “INAB”. The firm’s initial public offering is looking to raise US$40.0 million and is expected to close on August 3, 2021.

The offering consists of 4,000,000 common shares selling at US$10.00 per share. The company intends to use the proceeds of its offering on advancing the development of its two lead product candidates in T-cell therapies for treating cancer.

The company granted a 30-day over-allotment option to purchase additional 600,000 common shares at the same IPO price. B. Riley Securities, Inc. is acting as the sole bookrunner for the said offering.

The New York-based biotech company is focused on developing and commercializing gamma-delta T cells to treat cancer patients. The firm reported US$8.6 million net loss in 2020 and an approximately US$15 million cash balance as of March 31, 2021


Information for this briefing was found via Edgar and IN8bio. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

Antimony Resources Drills 5.27% Sb Over 4.95 Metres In Latest Results

Nord Precious Metals Identifies 29 Veins At Castle East Following 3D Modeling

Related News

Agritech Firm AgriFORCE Seeks To Raise US$13.6 Million In Its IPO

Agriculture-focused technology company AgriFORCE Growing Systems Ltd. goes public today on the Nasdaq Capital Market....

Thursday, July 8, 2021, 10:21:00 AM

Cannabis-Focused Investment Firm Silver Spike Looks To Raise US$85.0 Million On Its Nasdaq IPO

Management investment firm Silver Spike Investment Corp. (Nasdaq: SSIC) announced on Friday the pricing of...

Monday, February 7, 2022, 02:25:00 PM

European Investment Firm-Backed SPAC Springwater Special Situations Eyes US$150 Million IPO On Nasdaq

Special purpose acquisition company Springwater Special Situations Corp. (Nasdaq: SWSSU) started trading its securities on...

Thursday, August 26, 2021, 01:10:00 PM

Crypto Firm Argo Blockchain Prices US$112.5 Million IPO

Cryptocurrency mining company Argo Blockchain Plc (Nasdaq: ARBK) started trading on the Nasdaq Global Select...

Thursday, September 23, 2021, 03:48:00 PM

Cerebras Files for $1 Billion IPO, Poised to Battle NVIDIA in AI Tech Race

Cerebras Systems Inc., a California-based startup known for its high-performance AI chips, has formally filed...

Tuesday, October 1, 2024, 11:35:00 AM